<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Reproductive BioMedicine</title>
<title_fa>International Journal of Reproductive BioMedicine</title_fa>
<short_title>IJRM</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijrm.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2476-4108</journal_id_issn>
<journal_id_issn_online>2476-3772</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/ijrm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2023</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>21</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa>هیپرهموسیستئینمی و پیامدهای بارداری در زنان مبتلا به سندرم تخمدان پلی کیستیک: یک مطالعه مورد شاهدی</title_fa>
	<title>Hyperhomocysteinemia and pregnancy outcomes in women with polycystic ovary syndrome: A case-control study</title>
	<subject_fa></subject_fa>
	<subject>Reproductive Pattology</subject>
	<content_type_fa>Original Article</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;direction:rtl&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;مقدمه: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;یکی از چالش&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;های پزشکی تولید&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;مثل، تعیین نقش هیپرهموسیستئینمی در پاتوژنز سندرم تخمدان پلی&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;کیستیک (&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;) به ویژه در زنان با سقط مکرر (&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;RPL&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;) است.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;direction:rtl&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;هدف: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;تعیین ارتباط بین هیپرهموسیستئینمی و نتیجه بارداری در زنان مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;direction:rtl&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;مواد و روش&amp;shy;ها: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;این مطالعه مورد-شاهدی بر روی 245 زن (30-20 ساله) در گرجستان، تفلیس طی سال&#8204;های 2019-2022 انجام شد. از این تعداد 175 زن مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;(گروه مطالعه) و 70 زن سالم (گروه شاهد) بودند. زنان مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;به گروه اول با&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;RPL &lt;/span&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;nbsp;(90 نفر) و گروه دوم با تولد زنده (85 نفر) تقسیم شدند. گروه اول به زیرگروه&amp;shy;های &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;A&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; و &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;B&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; با و بدون مقاومت به انسولین تقسیم شدند. هموسیستئین (&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;Hcy&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;)، هورمون&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;های محرک فولیکول، لوتئینه&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;کننده، آنتی&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;مولرین و تستوسترون تام و آزاد اندازه&amp;shy;گیری شدند. برای تعیین حجم تخمدان و تعداد فولیکول&amp;shy;های آنترال، شرکت&amp;shy;کنندگان تحت معاینه اولتراسوند قرار گرفتند.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;direction:rtl&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;نتایج: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;در زنان مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;، میانگین سطح هموسیستئین به طور معنی&#8204;داری بیشتر از گروه شاهد بود 05/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;&gt; &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;. در گروه اول، میانگین سطح هموسیستئین به طور معنی&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;داری بیشتر از گروه دوم و گروه شاهد، 05/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;&gt; &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;بود. میانگین سطح &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;Hcy&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;بین گروه دوم و گروه شاهد تفاوت معنی&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;داری نداشت. میانگین سطح هموسیستئین در گروه اول، زیر گروه &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;A&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; به طور قابل توجهی بالاتر از زیر گروه &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;B&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; بود 05/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;&gt; &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;. میانگین سطح تام و آزاد تستوسترون و سطوح ارزیابی مدل هومئوستاتیک-مقاومت به انسولین (&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;HOMA-IR&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;) در گروه اول به طور قابل توجهی بیشتر از گروه دوم و گروه کنترل بود. &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;HOMA-IR&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; در گروه دوم و گروه شاهد تفاوت معنی&amp;shy;داری نداشت. میانگین سطح هورمون آنتی&amp;shy;مولرین در زنان مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;به طور قابل توجهی بالاتر از گروه شاهد بود 05/0 &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:10.0pt&quot;&gt;&gt; &lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;p&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;. تفاوت معنی&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;داری در میانگین سطح هورمون آنتی&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;مولرین، حجم تخمدان، تعداد فولیکول&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;های آنترال و شاخص توده بدنی بین گروه&lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span arial=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;shy;&lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;های مقایسه &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;PCOS&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;مشاهده نشد. در گروه اول همبستگی مثبت بین &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;Hcy&lt;/span&gt; &lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;با &lt;/span&gt;&lt;/span&gt;&lt;span dir=&quot;LTR&quot; style=&quot;font-size:10.0pt&quot;&gt;HOMA-IR&lt;/span&gt;&lt;span lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt; مشاهده شد.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;نتیجه&amp;shy;گیری:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;سطح سرمی &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Hcy&lt;/span&gt;&lt;/span&gt; &lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;در زنان مبتلا به &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;PCOS&lt;/span&gt;&lt;/span&gt; &lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;و &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;RPL&lt;/span&gt;&lt;/span&gt; &lt;span dir=&quot;RTL&quot; lang=&quot;FA&quot; style=&quot;font-size:11.0pt&quot;&gt;&lt;span b=&quot;&quot; mitra=&quot;&quot; style=&quot;font-family:&quot;&gt;افزایش می&amp;shy;یابد که با وضعیت مقاومت به انسولین آنها ارتباط دارد.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Background:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt; One of the &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;reproductive medicine&lt;span style=&quot;color:black&quot;&gt; challenges &lt;/span&gt;is to determine the role of hyperhomocysteinemia in the pathogenesis of polycystic ovary syndrome (PCOS), especially in women with recurrent pregnancy loss (RPL).&lt;/span&gt;&lt;span lang=&quot;GEO/KAT&quot; style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;Objective: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;D&lt;/span&gt;&lt;span lang=&quot;GEO/KAT&quot; style=&quot;font-size:12.0pt&quot;&gt;etermin&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;e&lt;/span&gt; &lt;span style=&quot;font-size:12.0pt&quot;&gt;the correlation&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt; between hyperhomocysteinemia and pregnancy outcome &lt;/span&gt;&lt;span lang=&quot;GEO/KAT&quot; style=&quot;font-size:12.0pt&quot;&gt;in women with PCOS&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;.&lt;span style=&quot;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;Material &lt;span style=&quot;background:white&quot;&gt;and &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;GEO/KAT&quot; style=&quot;font-size:12.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size:12.0pt&quot;&gt;This &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;&lt;span style=&quot;color:#212121&quot;&gt;case-control study&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt; involved &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;245 women &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;(20-30 yr)&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt; and was conducted in Georgia, Tbilisi from 2019-2022. Of these, 175 were women with PCOS (study group) and 70 were healthy women (control group). &lt;a name=&quot;_Hlk112491253&quot;&gt;Women&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt; with PCOS were divided into- group I with RPL (n = 90), and group II with live births (n = 85). Group I was divided into subgroups A and B with and without insulin resistance. The investigation measured homocysteine (Hcy), follicle-stimulating, luteinizing, &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;anti-Mullerian &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;hormones, total and free testosterone were determined. To determine the ovarian volume and antral follicle count, participants also underwent an ultrasound examination.&lt;span style=&quot;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size:12.0pt&quot;&gt;In women with PCOS,&lt;/span&gt; &lt;span style=&quot;font-size:12.0pt&quot;&gt;the average Hcy level &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;was significantly higher than in the controls, &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;p &lt; 0.05&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;. &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;In &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;group I, &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;the average Hcy level was significantly higher than &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;in group II and controls, &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;p &lt; 0.05&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;. There was no significant difference in average&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt; Hcy&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt; level between group II and controls. &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;The average Hcy level in group I, subgroup A was significantly higher than in subgroup B, p &lt; 0.05.&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt; The average total, free testosterone levels, and homeostatic model assessment-insulin resistance levels &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;(HOMA-IR) &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;in&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt; group I &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;was significantly higher than in group II and controls. &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;HOMA-IR in &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;group II and controls did not differ significantly. The average anti-Mullerian hormone levels in women with PCOS were significantly higher than controls, p &lt; &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;0.05&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;. No significant difference was observed in average anti-Mullerian hormone level, ovarian volume, antral follicle count, and &lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;b&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;ody mass index &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;between the comparison groups of PCOS. In group I, a positive correlation between Hcy with HOMA-IR was detected.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;Conclusion: &lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;Serum &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;Hcy&lt;span style=&quot;background:white&quot;&gt; levels are elevated in women with PCOS and RPL, which correlates with their insulin resistance status. &lt;strong&gt;&lt;i&gt;&lt;/i&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa>سندرم تخمدان پلی کیستیک, هیپرهموسیستئینمی, سقط مکرر, مقاومت به انسولین.</keyword_fa>
	<keyword>Polycystic ovary syndrome, Hyperhomocysteinemia, Recurrent abortion, Insulin resistance.</keyword>
	<start_page>167</start_page>
	<end_page>174</end_page>
	<web_url>http://ijrm.ir/browse.php?a_code=A-10-2239-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Elene</first_name>
	<middle_name></middle_name>
	<last_name>Asanidze</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>elene.asanidze@geomedi.edu.ge</email>
	<code></code>
	<orcid>0000-0002-8779-7731</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Medical Faculty of Teaching University Geomedi, Tbilisi, Georgia. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Jenaro </first_name>
	<middle_name></middle_name>
	<last_name>Kristesashvili</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>jenarakrist@hotmail.com</email>
	<code></code>
	<orcid>0000-0001-9216-1407</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medical Faculty of Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nino</first_name>
	<middle_name></middle_name>
	<last_name>Parunashvili</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>parunashvilin@gmail.com</email>
	<code></code>
	<orcid>0000-0001-6598-1266</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>University of Toronto, Faculty of Medicine, Physician Assistant Program, Toronto, Canada.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Manana</first_name>
	<middle_name></middle_name>
	<last_name>Urjumelashvili</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>m.urjumelashvili@gmail.com</email>
	<code></code>
	<orcid>0000-0002-5929-4424</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medical Faculty of Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zurab</first_name>
	<middle_name></middle_name>
	<last_name>Tsetskhladze</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zurab.tsetskhladze@geomedi.edu.ge</email>
	<code></code>
	<orcid>0000-0003-0774-0020</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Teaching University Geomedi, Tbilisi, Georgia.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Aleksandre</first_name>
	<middle_name></middle_name>
	<last_name>Asanidze</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>aleqsandreasanidze6@gmail.com</email>
	<code></code>
	<orcid>0000-0002-0363-3183</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Tbilisi State Medical University, Tbilisi, Georgia.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
